68 patient data entries collated from reference Tang et al, 2011. Entry # | Mutations | allele 1 | allele 2 |
| Clinical representation | Symptoms | Age group | Patient age | Age of onset | Age of death | | 4 | A467T2
| F88L1
| Clinical indications reported as N/A only information provided is age of patient and 71% mtDNA copy number in blood. | | | 42 | n/a | n/a | 5 | G848S1
| A143V1
| Evidence of maternal inheritance, developmental delay, hypotonia, dementia/encephalopathy, seizures, myoclonic seizures, hepatic failure, elevated transaminases, high CSF lactate, abnormal EEG, leukodystrophy, MRS/lactate peak, abnormal MRI. 71% mtDNA copy number in blood. | | | 4 | n/a | n/a | 6 | G848S1
| A143V1
| Ataxia, peripheral neuropathy, hearing loss, abnormal MRI, COX deficiency, developmental delay, seizure, delayed gastric emptying, CPK abnormalities, sister died at 2.5 years. 111% mtDNA copy number in blood. Patient II-49. | - | movement disorder (ataxia) | |
- | delayed gastric emptying | |
| | 38 | n/a | n/a | 7 | G848S1
| A143V1
| Seizures, intractable seizure, abnormal EEG, abnormal MRI. 43% mtDNA copy number in blood. | | | 8 | n/a | n/a | 8 | G848S1
| A143V1
| Leigh disease, developmental delay, FTT, abnormal EEG/MRI, hypotonia, seizures, vomiting, hemiplegia, behavior change. 136% mtDNA copy number in muscle and 57% mtDNA copy number in blood. | | | 4 | n/a | n/a | 9 | A467T2
| A143V1
| Dementia/encephalopathy, headaches/migraines, ataxia, seizures, peripheral neuropathy, exercise intolerance, muscle weakness, easy fatigability, CPEO, abnormal EMG/NCV, hearing loss, cerebellar atrophy, abnormal MRI. 82% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 49 | n/a | n/a | 10 | L304R3
| A143V1
| Cerebral cavernous malformation, teen onset CPEO. 110% mtDNA copy number in blood. | | | 22 | n/a | n/a | 25 | H932Y1
| T251I P587L2
| Peripheral neuropathy, exercise intolerance, muscle cramps after exercise, easy fatigability, arrythmia, CPEO, abnormal EMG/NCV, ptosis, cataract, abnormal muscle histology, abnormal muscle ultrastructure, COX deficiency, ragged red fibers. 123% mtDNA copy number in blood. | - | abnormal muscle histology | |
- | abnormal muscle ultrastructure | |
| | 31 | n/a | n/a | 26 | H932Y1
| T251I P587L2
| Peripheral neuropathy, ptosis, muscle weakness, CPK abnormalities. 77% mtDNA copy number in blood. | | | 41 | n/a | n/a | 27 | G848S1
| T251I P587L2
| Ocular bulbar weakness, peripheral neuropathy, muscle weakness, CPEO, ptosis, hypothyroidism, abnormal muscle histology, abnormal muscle ultrastructure, large mitochondrial proliferation, ragged red fibers. 96% mtDNA copy number in blood. Patient II-44. | - | abnormal muscle histology | |
- | abnormal muscle ultrastructure | |
| | 81 | n/a | n/a | 28 | K1191N1
| T251I P587L2
| Stroke/ischaemic episodes, peripheral neuropathy, CPEO, abnormal EMG/NCV, ptosis, muscle weakness, headache/migraine. 167% mtDNA copy number in blood. | | | 39 | n/a | n/a | 48 | N1157S1
| T251I P587L2
| N/A (as reported in Tang 2011 JMG) | | | 9 | n/a | n/a | 50 | L304R3
| L304R3
| Seizures, ptosis, elevated transaminases, lactic acidosis, elevated dopamine, abnormal MRI. 48% mtDNA copy number in muscle, 26% mtDNA copy number in liver. | | | 4 | n/a | n/a | 51 | L304R3
| L304R3
| CPEO, muscle weakness, ptosis, ataxia. 53% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 10 | n/a | n/a | 55 | L304R3
| L304R3
| CPEO, ptosis, ataxia, abnormal EMG/NCV, cerebellar atrophy, large mitochondrial proliferation, ragged red fibers, easy fatigability, abnormal muscle histology, hypotonia, lactic acidosis, high CSF lactate, organic aciduria/tiglyglycine, low plasma carnitine. 36% mtDNA copy number in muscle, 22% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
- | abnormal muscle histology | |
| | 9 | n/a | n/a | 56 | L304R3
| L304R3
| Peripheral neuropathy exercise intolerance, easy fatigability, CPEO, abnormal EMG/NCV, ptosis, lactic acidosis, CPK abnormalities, short stature, FTT, abnormal VERS, developmental delay, abnormal respiratory enzymes, ragged red fibers. 37% mtDNA copy number in muscle, 20% mtDNA copy number in blood. | | | 12 | n/a | n/a | 57 | L304R3
| L304R3
| Peripheral neuropathy, exercise intolerance, muscle weakness, abnormal EMG/NCV, ptosis, lactic acidosis, COX deficiency, CPEO. 58% mtDNA copy number in blood. | | | 9 | n/a | n/a | 58 | L304R3
| L304R3
| Peripheral neuropathy exercise intolerance, muscle weakness, easy fatigability, abnormal EMG/NCV, ptosis, CPK abnormalities, short stature, abnormal muscle histology, ragged red fibers, elevated pyruvate. 45% mtDNA copy number in blood. | - | abnormal muscle histology | |
| | 23 | n/a | n/a | 61 | G737R5
| L304R3
| Muscle weakness, ptosis, ophthalmoparesis/CPEO. 61% mtDNA copy number in blood. | | | 54 | n/a | n/a | 63 | R1081P3
| L304R3
| Age 10, encephalopathy, ataxia, seizures, myoclonic seizures, pyramidal signs, dystonia, choria, muscle weakness, CPEO, ptosis, elevated alanine, abnormal EEG, MRS/lactate peak. 79% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 10 | n/a | n/a | 65 | A467T2
| S305R3
| Liver failure. 51% mtDNA copy number in muscle, 9% mtDNA copy number in liver, 87% mtDNA copy number in blood. | | | 1 | n/a | n/a | 70 | R869Q1
| K319E3
| Headaches/migraines, ataxia, peripheral neuropathy, muscle weakness, CPEO, abnromal EMG/NCV, ptosis, CPF abnormalities, abnormal histology, abnormal muscle ultrastructure, COX deficiency, ragged red fibers. 114% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
- | abnormal muscle ultrastructure | |
| | 44 | n/a | n/a | 74 | G737R5
| G426S1
| Seizures, intractable seizures, abnormal EEG, abnormal MRI. 135% mtDNA copy number in blood. | | | 11 | n/a | n/a | 82 | A467T2
| A467T2
| Stroke/ischaemic episodes, ataxia, seizures, myoclonic seizures, peripheral neuropathy, CPEO. 114% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 40 | n/a | n/a | 83 | A467T2
| A467T2
| Age 19.6, developmental delay, after 18 years, rapid onset of muscle weakness, ataxia, myoclonic seizures, optic atrophy, diplopia, dysarthria. 102% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 20 | 18 | n/a | 86 | A467T2
| A467T2
| Ataxia, peripheral neuropathy, muscle weakness, easy fatigability, CPEO, abnormal EMG/NCV, ptosis, delayed gastric emptying, diarrhoea, constipation, lactic acidosis, abnormal muscle ultratstructure, ragged red fibers. 75% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
- | delayed gastric emptying | |
| | 46 | n/a | n/a | 93 | S1095R3
| A467T2
| Hypotonia, hepatic failure, elevated transaminases, respiratory deficiency/failure, FTT, developmental delay, GI reflux, delayed gastric emptying, dicarboxylic aciduria, high CSF protein, abnormal muscle histology, COX deficiency, vomiting. 12% mtDNA copy number in muscle, 42% mtDNA copy number in blood, ETC low. ptosis, poor head control. Central hypotonia, and absent deep tendon reflexes. He developed hypoxia, ascites, tachycardia, intermittent fevers, and sepsis. Some severely cytochrome oxidase-deficient muscle fibers were present. | - | abnormal muscle histology | |
- | delayed gastric emptying | |
| | n/a | 0.333 | 0.583 | 94 | R807C3
| A467T2
| Encephalopathy/dementia, liver failure, cholestasis, lactic acidosis, altered mental status. 47% mtDNA copy number in muscle, 8% mtDNA copy number in liver, ETC low. | | | 1 | n/a | n/a | 95 | R807H3
| A467T2
| Developmental delay, hypotonia, seizures, hepatic failure, elevated transaminases, renal tubular disease, failure to thrive. 18% mtDNA copy number in blood. | | | 1 | n/a | n/a | 97 | T914P1
| A467T2
| Developmental delay, hypotonia, seizures, myoclonic seizures, hemiparesis, intractable seizure, elevated transaminases, FTT, lactic acidosis, high CSF lactate, elevated pyruvate, high CSF protein, dementia/encephalopathy. 112% mtDNA copy number in muscle, 63% mtDNA copy number in blood. | | | 0.9 | n/a | n/a | 100 | T914P1
| A467T2
| Developmental delay, seizures, myoclonic seizures, intractable seizure, respiratory deficiency/failure, abnormal EEG, abnormal MRI. 60% mtDNA copy number in blood. | | | 0.8 | n/a | n/a | 101 | T914P1
| A467T2
| Developmental delay, hypotonia, dementia/encephalopathy, seizures, intractable seizure, lactic acidosis, high CSF lactate, abnormal MRI, no liver problem at 3.5 years. 24% mtDNA copy number in blood. | | | 3 | n/a | n/a | 102 | T914P1
| A467T2
| Seizures, hepatic failure, duplicated cyst of ileum, FTT, diarrhea. 13% mtDNA copy number in liver. | | | 4 | n/a | n/a | 103 | T914P1
| A467T2
| Developmental delay, headaches/migraines, seizures, hemiparesis, intractable seizure, high CSF lactate, high CSF protein, hearing loss, abnormal EEG, increased signal basal ganglia, abnormal MRI. 88% mtDNA copy number in blood. | | | 5 | n/a | n/a | 107 | C1188R1
| A467T2
| Developmental delay, seizures, abnormal MRI, hypotonia, low in blood. | | | 3 | n/a | n/a | 109 | R852C1 G11D
| A467T2
| Seizures, myoclonic seizures, intractable seizures, hepatic failure, elevated transaminases, Apnes/Hypoventilation, respiratory deficiency/failure, lactic acidosis, organic aciduria/tiglyglycine, low plasma carnitine, abnormal EEG. 108% mtDNA copy number in blood. | | | 0.8 | n/a | n/a | 114 | G588D2
| A467T2
| VPA induced liver failure. 50% mtDNA copy number in muscle. | | | 2 | n/a | n/a | 118 | H754Q2
| A467T2
| Developmental delay, intractable seizure/refractory, hepatic failure, cerebellar atrophy, liver failure. 87% mtDNA copy number in blood. | | | 2 | n/a | n/a | 120 | R597W2
| A467T2
| Dementia/encephalopathy, ataxia, peripheral neuropathy, ptosis, abnormal muscle histology, abnormal muscle ultrastructure, abnormal respiratory enzyms, large mitochondrial/ proliferation, COX deficiency, ragged red fibers. 100% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
- | abnormal muscle histology | |
- | abnormal muscle ultrastructure | |
| | 26 | n/a | n/a | 125 | W748S5
| A467T2
| Autistic features, headaches/migraines, ataxia, seizures, intractable seizure, optic atrophy, abnormal MRI, dystonia, posterior stroke, abnormal EEG. 101% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 18 | n/a | n/a | 126 | F749S5
| A467T2
| Intractable seizure, abrubt onset of seizure. 15% mtDNA copy number in blood. | | | 6 | n/a | n/a | 127 | L1113P1
| A467T2
| Encephalopathy, seizures, pancreatitis, hepatic failure, elevated transaminases, respiratory deficiency/failure, lactic acidosis, mycoplasma infection, pentobarbital induced liver failure. 57% mtDNA copy number in muscle, 78% mtDNA copy number in blood, Complex IV 20%. | | | 1 | n/a | n/a | 139 | R597W2
| R597W2
| Seizures and developing PEO, peripheral neuropathy, and death occurred after VPA treatment. 53% mtDNA copy number in muscle. | | | 18 | n/a | n/a | 146 | R852C1 G11D
| R627Q5
| Dementia/encephalopathy, infantile spasms, cerebral artery occlusion, headache/migraine, stroke, constipation. 74% mtDNA copy number in blood. | | | 25 | n/a | n/a | 152 | A957V1
| G737R5
| Deceased at 9 months. 30% mtDNA copy number in muscle, 30% mtDNA copy number in blood, 10% mtDNA copy number in liver. | | | 0.4 | n/a | 0.8 | 153 | V855L1
| G737R5
| Hypoglycaemia, liver failure, seizures, developmental delay. 65% mtDNA copy number in muscle, ETC low. | | | 0.8 | n/a | n/a | 158 | W748S5
| W748S5
| Ataxia, peripheral neuropathy, exercise intolerance, easy fatigueability, cerebellar atrophy, abnormal MRI. 82% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 30 | n/a | n/a | 161 | T914P1
| W748S5
| Age 0.8, developmental delay, hypotonia, myoclinic seizures, spasticity, dystonia, exercise intolerance, GI reflux, abnormal EEG, elevated transaminases, increased signal basal ganglia, abnormal MRI, lactic acidosis, high CSF lactate. | | | 0.8 | n/a | n/a | 162 | W748S5 S28C
| W748S5
| Headaches/migraines, ataxia, peripheral neuropathy, exercise intolerance, ophthalmoporesis/CPEO, abnormal EMG/NCV, ptosis, constipation, pseudo-obstruction, hearing loss, abnormal BAERS. 83% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 25 | n/a | n/a | 163 | T914P1
| W748S5
| Seizures. 98% mtDNA copy number in blood. | | | 5 | n/a | n/a | 165 | R852H1
| W748S5
| Alpers. 46% mtDNA copy number in blood. | | | 3 | n/a | n/a | 166 | R953C1
| W748S5
| Peripheral neuropathy, CPEO, ptosis, COX deficiency, ragged red fibers, headaches/migraines, diarrhoea, lactic acidosis, hypotonia, ataxia, myoclonic seizures, exercise intolerance, muscle weakness, muscle cramps after exercise, optic atrophy, easy fatigability. 61% mtDNA copy number in muscle, 61% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 51 | n/a | n/a | 171 | G848S1
| W748S5
| Headaches/migrains, seizures, intractable seizure, cortical blindness. 32% mtDNA copy number in blood. | | | 7 | n/a | n/a | 172 | G888D1
| W748S5
| Seizures, ptosis, hepatic failure, ketosis, lactic acidosis, organic aciduria/tiglyglycine, elevated pyruvate, microcephaly, abnormal MRI. 33% mtDNA copy number in muscle, 46% mtDNA copy number in blood, ETC low. | | | 2 | n/a | n/a | 173 | G848S1
| W748S5
| Hypotonia, myoclonus, or myoclonic seizures, intractable seizure, hepatic failure, abnormal EEG. 38% mtDNA copy number in blood. | | | 5 | n/a | n/a | 178 | A467T2
| F749S5
| Authors report N/A. 6% mtDNA copy number in blood. | | | 0.8 | n/a | n/a | 182 | R1096C3
| G848S1
| Developmental delay, hypotonia, dementia/encephalopathy, exercise intolerance, muscle weakness, easy fatigability, ptosis, GI reflux, delayed gastric emptying, cyclic vomiting, hepatic failure, elevated transaminases, lactic acidosis, short statue, FTT. 53% mtDNA copy number in blood. | - | delayed gastric emptying | |
| | 2 | n/a | n/a | 184 | P1073L3
| G848S1
| Hypotonia, FTT, gastro-oesophaeal reflux. 36% mtDNA copy number in muscle, 62% mtDNA copy number in blood. | | | 2 | n/a | n/a | 185 | G848S1
| G848S1
| Seizures, SIDS/unexplained death, MRS/lactate peak, abnormal MRI, abnormal respiratory enzymes. 7% mtDNA copy number in muscle. | | | 5 | n/a | n/a | 203 | A957V1
| S933R1
| Developmental delay, hypotonia, seizures, muscle weakness elevated transaminases, respiratory deficiency, lactic acidosis, high CSF lactate, elevate pyruvate, high CSF protein, abnormal EEG, abnormal MRI, FTT, hypoglycemia. 37% mtDNA copy number in muscle, 41% mtDNA copy number in blood. | | | 0.3 | n/a | n/a | 206 | | Y951N1
| Peripheral neuropathy, elevated 3-methylglutaconic acid. | | | 22 | n/a | n/a | 209 | | Y955C1
| CPEO, myopathy. | | | 45 | n/a | n/a | 211 | C1077G3
| A957V1
| Developmental delay, hypotonia, dementia/encephalopathy, seizures, myoclonic seizures, elevated transaminases, FTT, abnormal EEG. 81% mtDNA copy number in muscle, 27% mtDNA copy number in blood. | | | 2 | n/a | n/a | 216 | R964C1
| A962T1
| Ataxia, muscle weakness, central hypoventilation. 119% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | 14 | n/a | n/a | 223 | R1096C3
| R1096C3
| Seizures, liver failure. | | | 1 | n/a | n/a | 224 | R1096C3
| R1096C3
| Developmental delay, seizure, lactic acidosis, elevated transaminases. 50% mtDNA copy number in blood. | | | 2 | n/a | n/a | 225 | R1096C3
| R1096C3
| Seizures, dementia/encephalopathy. 56% mtDNA copy number in blood. | | | 0.8 | n/a | n/a | 524 | G517V2
| Y955C1
| Peripheral neuropathy, myopathy, ptosis, CPEO, COX deficiency, ragged red fibres | | | 47 | n/a | n/a |
1-5 pathogenic cluster assignment of mutations. Mutations displayed without a superscript number are outside of the assigned pathogenic clusters. See cluster definitions for details.
|